We have a significant presence in more than 100 countries with a growing reputation for excellence in emerging markets such as China, Mexico, Brazil and Russia.
We employ around 51,500 people worldwide: 34.8% in Europe, 21.7% in North America, 6% in Central and South America, 4.1% in the Middle East and Africa and 33.4% in Asia Pacific.
Around 9,800 people work in our R&D organisation and we have 10 principal R&D centres in six countries. We invest over $4 billion in R&D each year.
We have 10,300 employees at 22 Supply and Manufacturing sites in 16 countries across the world. We’re not exaggerating when we proudly claim that our manufacturing site in North Ryde, Sydney is one of the best in the world. We’re committed to high-tech manufacturing in Australia and as one of the largest exporters of medicines we contribute significantly to the wider success of the Australian economy.
For further information about AstraZeneca global please click here.